Vyzulta (latanoprostene bunod 0.024% ophthalmic solution) — Medica
Ocular hypertension
Initial criteria
- Patient has ocular hypertension OR open-angle glaucoma (including normal-tension glaucoma).
Reauthorization criteria
- Same as initial criteria.
Approval duration
1 year